Global Companion Diagnostics (CDx) Development Services Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Companion Diagnostics (CDx) Development Services Industry Forecast” looks at past sales and reviews total world Companion Diagnostics (CDx) Development Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Companion Diagnostics (CDx) Development Services sales for 2023 through 2029. With Companion Diagnostics (CDx) Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Diagnostics (CDx) Development Services industry.
This Insight Report provides a comprehensive analysis of the global Companion Diagnostics (CDx) Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Diagnostics (CDx) Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Diagnostics (CDx) Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Diagnostics (CDx) Development Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Diagnostics (CDx) Development Services.
The global Companion Diagnostics (CDx) Development Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Companion Diagnostics (CDx) Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Companion Diagnostics (CDx) Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Companion Diagnostics (CDx) Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Companion Diagnostics (CDx) Development Services players cover Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q? Solutions, ResearchDx, Almac Diagnostic Services, Biocartis and Cerba Research, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostics (CDx) Development Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Companion Diagnostics (CDx) Development Services Industry Forecast” looks at past sales and reviews total world Companion Diagnostics (CDx) Development Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Companion Diagnostics (CDx) Development Services sales for 2023 through 2029. With Companion Diagnostics (CDx) Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Diagnostics (CDx) Development Services industry.
This Insight Report provides a comprehensive analysis of the global Companion Diagnostics (CDx) Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Diagnostics (CDx) Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Diagnostics (CDx) Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Diagnostics (CDx) Development Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Diagnostics (CDx) Development Services.
The global Companion Diagnostics (CDx) Development Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Companion Diagnostics (CDx) Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Companion Diagnostics (CDx) Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Companion Diagnostics (CDx) Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Companion Diagnostics (CDx) Development Services players cover Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q? Solutions, ResearchDx, Almac Diagnostic Services, Biocartis and Cerba Research, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostics (CDx) Development Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Feasibility Studies
- Assay Development
- Analytical Validation
- Clinical Validation
- Others
- Infectious Diseases
- Neurological Disorders
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Geneuity-Clinical Research Services
- Interpace Biosciences
- Labcorp
- Quest Diagnostics
- Q? Solutions
- ResearchDx
- Almac Diagnostic Services
- Biocartis
- Cerba Research
- Eurofins Scientific
- MLM Medical Labs
- Qiagen
- BGI Genomics
- MEDx Translational Medicine
- Medical Biological Laboratories (MBL)
- Novogene
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostics (CDx) Development Services Market Size 2018-2029
2.1.2 Companion Diagnostics (CDx) Development Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Companion Diagnostics (CDx) Development Services Segment by Type
2.2.1 Feasibility Studies
2.2.2 Assay Development
2.2.3 Analytical Validation
2.2.4 Clinical Validation
2.2.5 Others
2.3 Companion Diagnostics (CDx) Development Services Market Size by Type
2.3.1 Companion Diagnostics (CDx) Development Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
2.4 Companion Diagnostics (CDx) Development Services Segment by Application
2.4.1 Infectious Diseases
2.4.2 Neurological Disorders
2.5 Companion Diagnostics (CDx) Development Services Market Size by Application
2.5.1 Companion Diagnostics (CDx) Development Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
3 COMPANION DIAGNOSTICS (CDX) DEVELOPMENT SERVICES MARKET SIZE BY PLAYER
3.1 Companion Diagnostics (CDx) Development Services Market Size Market Share by Players
3.1.1 Global Companion Diagnostics (CDx) Development Services Revenue by Players (2018-2023)
3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Companion Diagnostics (CDx) Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS (CDX) DEVELOPMENT SERVICES BY REGIONS
4.1 Companion Diagnostics (CDx) Development Services Market Size by Regions (2018-2023)
4.2 Americas Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
4.3 APAC Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
4.4 Europe Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023)
5.2 Americas Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
5.3 Americas Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023)
6.2 APAC Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
6.3 APAC Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Companion Diagnostics (CDx) Development Services by Country (2018-2023)
7.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostics (CDx) Development Services by Region (2018-2023)
8.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPANION DIAGNOSTICS (CDX) DEVELOPMENT SERVICES MARKET FORECAST
10.1 Global Companion Diagnostics (CDx) Development Services Forecast by Regions (2024-2029)
10.1.1 Global Companion Diagnostics (CDx) Development Services Forecast by Regions (2024-2029)
10.1.2 Americas Companion Diagnostics (CDx) Development Services Forecast
10.1.3 APAC Companion Diagnostics (CDx) Development Services Forecast
10.1.4 Europe Companion Diagnostics (CDx) Development Services Forecast
10.1.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Forecast
10.2 Americas Companion Diagnostics (CDx) Development Services Forecast by Country (2024-2029)
10.2.1 United States Companion Diagnostics (CDx) Development Services Market Forecast
10.2.2 Canada Companion Diagnostics (CDx) Development Services Market Forecast
10.2.3 Mexico Companion Diagnostics (CDx) Development Services Market Forecast
10.2.4 Brazil Companion Diagnostics (CDx) Development Services Market Forecast
10.3 APAC Companion Diagnostics (CDx) Development Services Forecast by Region (2024-2029)
10.3.1 China Companion Diagnostics (CDx) Development Services Market Forecast
10.3.2 Japan Companion Diagnostics (CDx) Development Services Market Forecast
10.3.3 Korea Companion Diagnostics (CDx) Development Services Market Forecast
10.3.4 Southeast Asia Companion Diagnostics (CDx) Development Services Market Forecast
10.3.5 India Companion Diagnostics (CDx) Development Services Market Forecast
10.3.6 Australia Companion Diagnostics (CDx) Development Services Market Forecast
10.4 Europe Companion Diagnostics (CDx) Development Services Forecast by Country (2024-2029)
10.4.1 Germany Companion Diagnostics (CDx) Development Services Market Forecast
10.4.2 France Companion Diagnostics (CDx) Development Services Market Forecast
10.4.3 UK Companion Diagnostics (CDx) Development Services Market Forecast
10.4.4 Italy Companion Diagnostics (CDx) Development Services Market Forecast
10.4.5 Russia Companion Diagnostics (CDx) Development Services Market Forecast
10.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Forecast by Region (2024-2029)
10.5.1 Egypt Companion Diagnostics (CDx) Development Services Market Forecast
10.5.2 South Africa Companion Diagnostics (CDx) Development Services Market Forecast
10.5.3 Israel Companion Diagnostics (CDx) Development Services Market Forecast
10.5.4 Turkey Companion Diagnostics (CDx) Development Services Market Forecast
10.5.5 GCC Countries Companion Diagnostics (CDx) Development Services Market Forecast
10.6 Global Companion Diagnostics (CDx) Development Services Forecast by Type (2024-2029)
10.7 Global Companion Diagnostics (CDx) Development Services Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Geneuity-Clinical Research Services
11.1.1 Geneuity-Clinical Research Services Company Information
11.1.2 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offered
11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Geneuity-Clinical Research Services Main Business Overview
11.1.5 Geneuity-Clinical Research Services Latest Developments
11.2 Interpace Biosciences
11.2.1 Interpace Biosciences Company Information
11.2.2 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offered
11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Interpace Biosciences Main Business Overview
11.2.5 Interpace Biosciences Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Companion Diagnostics (CDx) Development Services Product Offered
11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offered
11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 Q? Solutions
11.5.1 Q? Solutions Company Information
11.5.2 Q? Solutions Companion Diagnostics (CDx) Development Services Product Offered
11.5.3 Q? Solutions Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Q? Solutions Main Business Overview
11.5.5 Q? Solutions Latest Developments
11.6 ResearchDx
11.6.1 ResearchDx Company Information
11.6.2 ResearchDx Companion Diagnostics (CDx) Development Services Product Offered
11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 ResearchDx Main Business Overview
11.6.5 ResearchDx Latest Developments
11.7 Almac Diagnostic Services
11.7.1 Almac Diagnostic Services Company Information
11.7.2 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offered
11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Almac Diagnostic Services Main Business Overview
11.7.5 Almac Diagnostic Services Latest Developments
11.8 Biocartis
11.8.1 Biocartis Company Information
11.8.2 Biocartis Companion Diagnostics (CDx) Development Services Product Offered
11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Biocartis Main Business Overview
11.8.5 Biocartis Latest Developments
11.9 Cerba Research
11.9.1 Cerba Research Company Information
11.9.2 Cerba Research Companion Diagnostics (CDx) Development Services Product Offered
11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cerba Research Main Business Overview
11.9.5 Cerba Research Latest Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Information
11.10.2 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offered
11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurofins Scientific Main Business Overview
11.10.5 Eurofins Scientific Latest Developments
11.11 MLM Medical Labs
11.11.1 MLM Medical Labs Company Information
11.11.2 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offered
11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 MLM Medical Labs Main Business Overview
11.11.5 MLM Medical Labs Latest Developments
11.12 Qiagen
11.12.1 Qiagen Company Information
11.12.2 Qiagen Companion Diagnostics (CDx) Development Services Product Offered
11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Qiagen Main Business Overview
11.12.5 Qiagen Latest Developments
11.13 BGI Genomics
11.13.1 BGI Genomics Company Information
11.13.2 BGI Genomics Companion Diagnostics (CDx) Development Services Product Offered
11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 BGI Genomics Main Business Overview
11.13.5 BGI Genomics Latest Developments
11.14 MEDx Translational Medicine
11.14.1 MEDx Translational Medicine Company Information
11.14.2 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offered
11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 MEDx Translational Medicine Main Business Overview
11.14.5 MEDx Translational Medicine Latest Developments
11.15 Medical Biological Laboratories (MBL)
11.15.1 Medical Biological Laboratories (MBL) Company Information
11.15.2 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offered
11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Medical Biological Laboratories (MBL) Main Business Overview
11.15.5 Medical Biological Laboratories (MBL) Latest Developments
11.16 Novogene
11.16.1 Novogene Company Information
11.16.2 Novogene Companion Diagnostics (CDx) Development Services Product Offered
11.16.3 Novogene Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Novogene Main Business Overview
11.16.5 Novogene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostics (CDx) Development Services Market Size 2018-2029
2.1.2 Companion Diagnostics (CDx) Development Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Companion Diagnostics (CDx) Development Services Segment by Type
2.2.1 Feasibility Studies
2.2.2 Assay Development
2.2.3 Analytical Validation
2.2.4 Clinical Validation
2.2.5 Others
2.3 Companion Diagnostics (CDx) Development Services Market Size by Type
2.3.1 Companion Diagnostics (CDx) Development Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
2.4 Companion Diagnostics (CDx) Development Services Segment by Application
2.4.1 Infectious Diseases
2.4.2 Neurological Disorders
2.5 Companion Diagnostics (CDx) Development Services Market Size by Application
2.5.1 Companion Diagnostics (CDx) Development Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
3 COMPANION DIAGNOSTICS (CDX) DEVELOPMENT SERVICES MARKET SIZE BY PLAYER
3.1 Companion Diagnostics (CDx) Development Services Market Size Market Share by Players
3.1.1 Global Companion Diagnostics (CDx) Development Services Revenue by Players (2018-2023)
3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Companion Diagnostics (CDx) Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS (CDX) DEVELOPMENT SERVICES BY REGIONS
4.1 Companion Diagnostics (CDx) Development Services Market Size by Regions (2018-2023)
4.2 Americas Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
4.3 APAC Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
4.4 Europe Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023)
5.2 Americas Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
5.3 Americas Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023)
6.2 APAC Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
6.3 APAC Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Companion Diagnostics (CDx) Development Services by Country (2018-2023)
7.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostics (CDx) Development Services by Region (2018-2023)
8.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPANION DIAGNOSTICS (CDX) DEVELOPMENT SERVICES MARKET FORECAST
10.1 Global Companion Diagnostics (CDx) Development Services Forecast by Regions (2024-2029)
10.1.1 Global Companion Diagnostics (CDx) Development Services Forecast by Regions (2024-2029)
10.1.2 Americas Companion Diagnostics (CDx) Development Services Forecast
10.1.3 APAC Companion Diagnostics (CDx) Development Services Forecast
10.1.4 Europe Companion Diagnostics (CDx) Development Services Forecast
10.1.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Forecast
10.2 Americas Companion Diagnostics (CDx) Development Services Forecast by Country (2024-2029)
10.2.1 United States Companion Diagnostics (CDx) Development Services Market Forecast
10.2.2 Canada Companion Diagnostics (CDx) Development Services Market Forecast
10.2.3 Mexico Companion Diagnostics (CDx) Development Services Market Forecast
10.2.4 Brazil Companion Diagnostics (CDx) Development Services Market Forecast
10.3 APAC Companion Diagnostics (CDx) Development Services Forecast by Region (2024-2029)
10.3.1 China Companion Diagnostics (CDx) Development Services Market Forecast
10.3.2 Japan Companion Diagnostics (CDx) Development Services Market Forecast
10.3.3 Korea Companion Diagnostics (CDx) Development Services Market Forecast
10.3.4 Southeast Asia Companion Diagnostics (CDx) Development Services Market Forecast
10.3.5 India Companion Diagnostics (CDx) Development Services Market Forecast
10.3.6 Australia Companion Diagnostics (CDx) Development Services Market Forecast
10.4 Europe Companion Diagnostics (CDx) Development Services Forecast by Country (2024-2029)
10.4.1 Germany Companion Diagnostics (CDx) Development Services Market Forecast
10.4.2 France Companion Diagnostics (CDx) Development Services Market Forecast
10.4.3 UK Companion Diagnostics (CDx) Development Services Market Forecast
10.4.4 Italy Companion Diagnostics (CDx) Development Services Market Forecast
10.4.5 Russia Companion Diagnostics (CDx) Development Services Market Forecast
10.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Forecast by Region (2024-2029)
10.5.1 Egypt Companion Diagnostics (CDx) Development Services Market Forecast
10.5.2 South Africa Companion Diagnostics (CDx) Development Services Market Forecast
10.5.3 Israel Companion Diagnostics (CDx) Development Services Market Forecast
10.5.4 Turkey Companion Diagnostics (CDx) Development Services Market Forecast
10.5.5 GCC Countries Companion Diagnostics (CDx) Development Services Market Forecast
10.6 Global Companion Diagnostics (CDx) Development Services Forecast by Type (2024-2029)
10.7 Global Companion Diagnostics (CDx) Development Services Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Geneuity-Clinical Research Services
11.1.1 Geneuity-Clinical Research Services Company Information
11.1.2 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offered
11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Geneuity-Clinical Research Services Main Business Overview
11.1.5 Geneuity-Clinical Research Services Latest Developments
11.2 Interpace Biosciences
11.2.1 Interpace Biosciences Company Information
11.2.2 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offered
11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Interpace Biosciences Main Business Overview
11.2.5 Interpace Biosciences Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Companion Diagnostics (CDx) Development Services Product Offered
11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offered
11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 Q? Solutions
11.5.1 Q? Solutions Company Information
11.5.2 Q? Solutions Companion Diagnostics (CDx) Development Services Product Offered
11.5.3 Q? Solutions Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Q? Solutions Main Business Overview
11.5.5 Q? Solutions Latest Developments
11.6 ResearchDx
11.6.1 ResearchDx Company Information
11.6.2 ResearchDx Companion Diagnostics (CDx) Development Services Product Offered
11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 ResearchDx Main Business Overview
11.6.5 ResearchDx Latest Developments
11.7 Almac Diagnostic Services
11.7.1 Almac Diagnostic Services Company Information
11.7.2 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offered
11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Almac Diagnostic Services Main Business Overview
11.7.5 Almac Diagnostic Services Latest Developments
11.8 Biocartis
11.8.1 Biocartis Company Information
11.8.2 Biocartis Companion Diagnostics (CDx) Development Services Product Offered
11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Biocartis Main Business Overview
11.8.5 Biocartis Latest Developments
11.9 Cerba Research
11.9.1 Cerba Research Company Information
11.9.2 Cerba Research Companion Diagnostics (CDx) Development Services Product Offered
11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cerba Research Main Business Overview
11.9.5 Cerba Research Latest Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Information
11.10.2 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offered
11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurofins Scientific Main Business Overview
11.10.5 Eurofins Scientific Latest Developments
11.11 MLM Medical Labs
11.11.1 MLM Medical Labs Company Information
11.11.2 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offered
11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 MLM Medical Labs Main Business Overview
11.11.5 MLM Medical Labs Latest Developments
11.12 Qiagen
11.12.1 Qiagen Company Information
11.12.2 Qiagen Companion Diagnostics (CDx) Development Services Product Offered
11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Qiagen Main Business Overview
11.12.5 Qiagen Latest Developments
11.13 BGI Genomics
11.13.1 BGI Genomics Company Information
11.13.2 BGI Genomics Companion Diagnostics (CDx) Development Services Product Offered
11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 BGI Genomics Main Business Overview
11.13.5 BGI Genomics Latest Developments
11.14 MEDx Translational Medicine
11.14.1 MEDx Translational Medicine Company Information
11.14.2 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offered
11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 MEDx Translational Medicine Main Business Overview
11.14.5 MEDx Translational Medicine Latest Developments
11.15 Medical Biological Laboratories (MBL)
11.15.1 Medical Biological Laboratories (MBL) Company Information
11.15.2 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offered
11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Medical Biological Laboratories (MBL) Main Business Overview
11.15.5 Medical Biological Laboratories (MBL) Latest Developments
11.16 Novogene
11.16.1 Novogene Company Information
11.16.2 Novogene Companion Diagnostics (CDx) Development Services Product Offered
11.16.3 Novogene Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Novogene Main Business Overview
11.16.5 Novogene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Companion Diagnostics (CDx) Development Services Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Feasibility Studies
Table 3. Major Players of Assay Development
Table 4. Major Players of Analytical Validation
Table 5. Major Players of Clinical Validation
Table 6. Major Players of Others
Table 7. Companion Diagnostics (CDx) Development Services Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 10. Companion Diagnostics (CDx) Development Services Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 13. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Player (2018-2023)
Table 15. Companion Diagnostics (CDx) Development Services Key Players Head office and Products Offered
Table 16. Companion Diagnostics (CDx) Development Services Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Companion Diagnostics (CDx) Development Services Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Regions (2018-2023)
Table 21. Global Companion Diagnostics (CDx) Development Services Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Country (2018-2023)
Table 25. Americas Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 27. Americas Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 29. APAC Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2018-2023)
Table 31. APAC Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 33. APAC Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 35. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Country (2018-2023)
Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 39. Europe Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Companion Diagnostics (CDx) Development Services
Table 48. Key Market Challenges & Risks of Companion Diagnostics (CDx) Development Services
Table 49. Key Industry Trends of Companion Diagnostics (CDx) Development Services
Table 50. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Geneuity-Clinical Research Services Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 55. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offered
Table 56. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Geneuity-Clinical Research Services Main Business
Table 58. Geneuity-Clinical Research Services Latest Developments
Table 59. Interpace Biosciences Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 60. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offered
Table 61. Interpace Biosciences Main Business
Table 62. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Interpace Biosciences Latest Developments
Table 64. Labcorp Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 65. Labcorp Companion Diagnostics (CDx) Development Services Product Offered
Table 66. Labcorp Main Business
Table 67. Labcorp Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Labcorp Latest Developments
Table 69. Quest Diagnostics Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 70. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offered
Table 71. Quest Diagnostics Main Business
Table 72. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Quest Diagnostics Latest Developments
Table 74. Q? Solutions Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 75. Q? Solutions Companion Diagnostics (CDx) Development Services Product Offered
Table 76. Q? Solutions Main Business
Table 77. Q? Solutions Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Q? Solutions Latest Developments
Table 79. ResearchDx Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 80. ResearchDx Companion Diagnostics (CDx) Development Services Product Offered
Table 81. ResearchDx Main Business
Table 82. ResearchDx Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. ResearchDx Latest Developments
Table 84. Almac Diagnostic Services Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 85. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offered
Table 86. Almac Diagnostic Services Main Business
Table 87. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Almac Diagnostic Services Latest Developments
Table 89. Biocartis Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 90. Biocartis Companion Diagnostics (CDx) Development Services Product Offered
Table 91. Biocartis Main Business
Table 92. Biocartis Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Biocartis Latest Developments
Table 94. Cerba Research Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 95. Cerba Research Companion Diagnostics (CDx) Development Services Product Offered
Table 96. Cerba Research Main Business
Table 97. Cerba Research Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Cerba Research Latest Developments
Table 99. Eurofins Scientific Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 100. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offered
Table 101. Eurofins Scientific Main Business
Table 102. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Eurofins Scientific Latest Developments
Table 104. MLM Medical Labs Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 105. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offered
Table 106. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. MLM Medical Labs Main Business
Table 108. MLM Medical Labs Latest Developments
Table 109. Qiagen Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 110. Qiagen Companion Diagnostics (CDx) Development Services Product Offered
Table 111. Qiagen Main Business
Table 112. Qiagen Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Qiagen Latest Developments
Table 114. BGI Genomics Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 115. BGI Genomics Companion Diagnostics (CDx) Development Services Product Offered
Table 116. BGI Genomics Main Business
Table 117. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. BGI Genomics Latest Developments
Table 119. MEDx Translational Medicine Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 120. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offered
Table 121. MEDx Translational Medicine Main Business
Table 122. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. MEDx Translational Medicine Latest Developments
Table 124. Medical Biological Laboratories (MBL) Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 125. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offered
Table 126. Medical Biological Laboratories (MBL) Main Business
Table 127. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Medical Biological Laboratories (MBL) Latest Developments
Table 129. Novogene Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 130. Novogene Companion Diagnostics (CDx) Development Services Product Offered
Table 131. Novogene Main Business
Table 132. Novogene Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Novogene Latest Developments
Table 1. Companion Diagnostics (CDx) Development Services Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Feasibility Studies
Table 3. Major Players of Assay Development
Table 4. Major Players of Analytical Validation
Table 5. Major Players of Clinical Validation
Table 6. Major Players of Others
Table 7. Companion Diagnostics (CDx) Development Services Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 10. Companion Diagnostics (CDx) Development Services Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 13. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Player (2018-2023)
Table 15. Companion Diagnostics (CDx) Development Services Key Players Head office and Products Offered
Table 16. Companion Diagnostics (CDx) Development Services Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Companion Diagnostics (CDx) Development Services Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Regions (2018-2023)
Table 21. Global Companion Diagnostics (CDx) Development Services Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Country (2018-2023)
Table 25. Americas Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 27. Americas Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 29. APAC Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2018-2023)
Table 31. APAC Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 33. APAC Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 35. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Country (2018-2023)
Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 39. Europe Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Companion Diagnostics (CDx) Development Services
Table 48. Key Market Challenges & Risks of Companion Diagnostics (CDx) Development Services
Table 49. Key Industry Trends of Companion Diagnostics (CDx) Development Services
Table 50. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Geneuity-Clinical Research Services Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 55. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offered
Table 56. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Geneuity-Clinical Research Services Main Business
Table 58. Geneuity-Clinical Research Services Latest Developments
Table 59. Interpace Biosciences Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 60. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offered
Table 61. Interpace Biosciences Main Business
Table 62. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Interpace Biosciences Latest Developments
Table 64. Labcorp Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 65. Labcorp Companion Diagnostics (CDx) Development Services Product Offered
Table 66. Labcorp Main Business
Table 67. Labcorp Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Labcorp Latest Developments
Table 69. Quest Diagnostics Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 70. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offered
Table 71. Quest Diagnostics Main Business
Table 72. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Quest Diagnostics Latest Developments
Table 74. Q? Solutions Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 75. Q? Solutions Companion Diagnostics (CDx) Development Services Product Offered
Table 76. Q? Solutions Main Business
Table 77. Q? Solutions Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Q? Solutions Latest Developments
Table 79. ResearchDx Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 80. ResearchDx Companion Diagnostics (CDx) Development Services Product Offered
Table 81. ResearchDx Main Business
Table 82. ResearchDx Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. ResearchDx Latest Developments
Table 84. Almac Diagnostic Services Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 85. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offered
Table 86. Almac Diagnostic Services Main Business
Table 87. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Almac Diagnostic Services Latest Developments
Table 89. Biocartis Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 90. Biocartis Companion Diagnostics (CDx) Development Services Product Offered
Table 91. Biocartis Main Business
Table 92. Biocartis Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Biocartis Latest Developments
Table 94. Cerba Research Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 95. Cerba Research Companion Diagnostics (CDx) Development Services Product Offered
Table 96. Cerba Research Main Business
Table 97. Cerba Research Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Cerba Research Latest Developments
Table 99. Eurofins Scientific Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 100. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offered
Table 101. Eurofins Scientific Main Business
Table 102. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Eurofins Scientific Latest Developments
Table 104. MLM Medical Labs Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 105. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offered
Table 106. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. MLM Medical Labs Main Business
Table 108. MLM Medical Labs Latest Developments
Table 109. Qiagen Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 110. Qiagen Companion Diagnostics (CDx) Development Services Product Offered
Table 111. Qiagen Main Business
Table 112. Qiagen Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Qiagen Latest Developments
Table 114. BGI Genomics Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 115. BGI Genomics Companion Diagnostics (CDx) Development Services Product Offered
Table 116. BGI Genomics Main Business
Table 117. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. BGI Genomics Latest Developments
Table 119. MEDx Translational Medicine Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 120. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offered
Table 121. MEDx Translational Medicine Main Business
Table 122. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. MEDx Translational Medicine Latest Developments
Table 124. Medical Biological Laboratories (MBL) Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 125. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offered
Table 126. Medical Biological Laboratories (MBL) Main Business
Table 127. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Medical Biological Laboratories (MBL) Latest Developments
Table 129. Novogene Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors
Table 130. Novogene Companion Diagnostics (CDx) Development Services Product Offered
Table 131. Novogene Main Business
Table 132. Novogene Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Novogene Latest Developments
LIST OF FIGURES
Figure 1. Companion Diagnostics (CDx) Development Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Companion Diagnostics (CDx) Development Services Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Companion Diagnostics (CDx) Development Services Sales Market Share by Country/Region (2022)
Figure 8. Companion Diagnostics (CDx) Development Services Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2022
Figure 10. Companion Diagnostics (CDx) Development Services in Infectious Diseases
Figure 11. Global Companion Diagnostics (CDx) Development Services Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 12. Companion Diagnostics (CDx) Development Services in Neurological Disorders
Figure 13. Global Companion Diagnostics (CDx) Development Services Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 14. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2022
Figure 15. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Player in 2022
Figure 16. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 18. APAC Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 19. Europe Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 21. Americas Companion Diagnostics (CDx) Development Services Value Market Share by Country in 2022
Figure 22. United States Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Region in 2022
Figure 27. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2022
Figure 28. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2022
Figure 29. China Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Country in 2022
Figure 36. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Figure 37. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Figure 38. Germany Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 52. APAC Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 53. Europe Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 55. United States Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 56. Canada Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 59. China Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 60. Japan Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 61. Korea Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 63. India Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 64. Australia Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 65. Germany Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 66. France Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 67. UK Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 68. Italy Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 69. Russia Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 70. Spain Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 73. Israel Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 76. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Companion Diagnostics (CDx) Development Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Companion Diagnostics (CDx) Development Services Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Companion Diagnostics (CDx) Development Services Sales Market Share by Country/Region (2022)
Figure 8. Companion Diagnostics (CDx) Development Services Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2022
Figure 10. Companion Diagnostics (CDx) Development Services in Infectious Diseases
Figure 11. Global Companion Diagnostics (CDx) Development Services Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 12. Companion Diagnostics (CDx) Development Services in Neurological Disorders
Figure 13. Global Companion Diagnostics (CDx) Development Services Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 14. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2022
Figure 15. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Player in 2022
Figure 16. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 18. APAC Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 19. Europe Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size 2018-2023 ($ Millions)
Figure 21. Americas Companion Diagnostics (CDx) Development Services Value Market Share by Country in 2022
Figure 22. United States Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Region in 2022
Figure 27. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2022
Figure 28. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2022
Figure 29. China Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Country in 2022
Figure 36. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Figure 37. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Figure 38. Germany Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Companion Diagnostics (CDx) Development Services Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 52. APAC Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 53. Europe Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 55. United States Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 56. Canada Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 59. China Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 60. Japan Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 61. Korea Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 63. India Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 64. Australia Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 65. Germany Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 66. France Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 67. UK Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 68. Italy Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 69. Russia Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 70. Spain Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 73. Israel Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Companion Diagnostics (CDx) Development Services Market Size 2024-2029 ($ Millions)
Figure 76. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Application (2024-2029)
